两家公司表示,在合作的初始阶段,Ares开发了一个数字抗感染平台,将微生物学实验室实践与先进的生物信息学和人工智能方法相结合,以帮助识别有效的抗菌化合物...查看全文
蹊之美股生物医药2021-10-08 00:15
作者:林出
微信公众号:蹊之美股生物医药 / CaesarBiotech
Gainers:
Voyager Therapeutics (NASDAQ:VYGR) +56%
Acer Therapeutics (NASDAQ:ACER) +16%
Molecular Partners (NASDAQ:MOLN) +10%
Rafael (NYSE:RFL) +6%
Arcturus Therapeutics (NASDA...查看全文
东哥_Singapore2021-03-08 23:42
$Jaguar Health(JAGX)$ 给力点啊,速度冲2.5!刚才在2.9的OPGN跟1.85的你之间,最后选的你!不要让我失望啊!OPGN已经爆拉了!!!$OpGen(OPGN)$查看全文
$OpGen, Inc.(OPGN)$ 424B3 - Prospectus [Rule 424(b)(3)] Filed: 2018-10-16 AccNo: 0001079973-18-000560 Size: 22 KB 网页链接
$OpGen, Inc.(OPGN)$ 8-K - Current report Filed: 2018-10-16 AccNo: 0001079973-18-000557 Size: 34 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$OpGen, Inc.(OPGN)$ 424B3 - Prospectus [Rule 424(b)(3)] Filed: 2018-09-26 AccNo: 0001079973-18-000534 Size: 30 KB 网页链接
$OpGen, Inc.(OPGN)$ 424B3 - Prospectus [Rule 424(b)(3)] Filed: 2018-09-26 AccNo: 0001079973-18-000533 Size: 30 KB 网页链接
$OpGen, Inc.(OPGN)$ 8-K - Current report Filed: 2018-09-25 AccNo: 0001079973-18-000524 Size: 332 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain OfficersItem 9.01: Financial ...
$OpGen, Inc.(OPGN)$ 8-K - Current report Filed: 2018-09-24 AccNo: 0001079973-18-000519 Size: 39 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$OpGen, Inc.(OPGN)$ SC 13D/A [Amend] - General statement of acquisition of beneficial ownership Filed: 2018-08-09 AccNo: 0001193125-18-244309 Size: 111 KB 网页链接
$OpGen, Inc.(OPGN)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2018-08-08 AccNo: 0001564590-18-020457 Size: 5 MB 网页链接
$OpGen, Inc.(OPGN)$ 424B3 - Prospectus [Rule 424(b)(3)] Filed: 2018-08-08 AccNo: 0001079973-18-000450 Size: 1 MB 网页链接
$OpGen, Inc.(OPGN)$ 424B3 - Prospectus [Rule 424(b)(3)] Filed: 2018-08-08 AccNo: 0001079973-18-000448 Size: 1 MB 网页链接